Follow
Michael A. Rogawski
Michael A. Rogawski
Professor of Neurology and Pharmacology, University of California,Davis
Verified email at ucdavis.edu - Homepage
Title
Cited by
Cited by
Year
The neurobiology of antiepileptic drugs
MA Rogawski, W Löscher
Nature reviews neuroscience 5 (7), 553-564, 2004
14602004
d-Serine is an endogenous ligand for the glycine site of the N-methyl-d-aspartate receptor
JP Mothet, AT Parent, H Wolosker, RO Brady Jr, DJ Linden, CD Ferris, ...
Proceedings of the National Academy of Sciences 97 (9), 4926-4931, 2000
13582000
Antiepileptic drugs Pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds
MA Rogawski
Pharmacol. Rev. 42, 223-286, 1990
9291990
Glia and epilepsy: excitability and inflammation
O Devinsky, A Vezzani, S Najjar, NC De Lanerolle, MA Rogawski
Trends in neurosciences 36 (3), 174-184, 2013
8492013
Neuroprotective and disease-modifying effects of the ketogenic diet
M Gasior, MA Rogawski, AL Hartman
Behavioural pharmacology 17 (5-6), 431-439, 2006
6412006
Molecular targets for antiepileptic drug development
BS Meldrum, MA Rogawski
Neurotherapeutics 4 (1), 18-61, 2007
5952007
The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions
MA Rogawski, W Löscher
Nature medicine 10 (7), 685-692, 2004
5672004
The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease
MA Rogawski, GL Wenk
CNS drug reviews 9 (3), 275-308, 2003
5542003
Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304
JA French, GL Krauss, V Biton, D Squillacote, H Yang, A Laurenza, ...
Neurology 79 (6), 589-596, 2012
5482012
Colchicine myopathy and neuropathy
RW Kuncl, G Duncan, D Watson, K Alderson, MA Rogawski, M Peper
New England Journal of Medicine 316 (25), 1562-1568, 1987
5021987
GYKI 52466, a 2, 3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses
SD Donevan, MA Rogawski
Neuron 10 (1), 51-59, 1993
4401993
Anticonvulsant activity of neurosteroids: correlation with gamma-aminobutyric acid-evoked chloride current potentiation.
TG Kokate, BE Svensson, MA Rogawski
Journal of Pharmacology and Experimental Therapeutics 270 (3), 1223-1229, 1994
4371994
Diverse mechanisms of antiepileptic drugs in the development pipeline
MA Rogawski
Epilepsy research 69 (3), 273-294, 2006
4342006
Revisiting AMPA receptors as an antiepileptic drug target: revisiting AMPA receptors as an antiepileptic drug target
MA Rogawski
Epilepsy currents 11 (2), 56-63, 2011
4222011
Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2, 3-benzodiazepines
MA Rogawski
Trends in pharmacological sciences 14 (9), 325-331, 1993
4151993
The A-current: how ubiquitous a feature of excitable cells is it?
MA Rogawski
Trends in Neurosciences 8, 214-219, 1985
4111985
The neuropharmacology of the ketogenic diet
AL Hartman, M Gasior, EPG Vining, MA Rogawski
Pediatric neurology 36 (5), 281-292, 2007
3922007
“Jasper’s basic mechanisms of the epilepsies” workshop
JL Noebels, M Avoli, M Rogawski, R Olsen, AV Delgado‐Escueta
Epilepsia 51, 1-5, 2010
354*2010
Stress-induced deoxycorticosterone-derived neurosteroids modulate GABAA receptor function and seizure susceptibility
DS Reddy, MA Rogawski
Journal of Neuroscience 22 (9), 3795-3805, 2002
3242002
Mechanisms of action of currently used antiseizure drugs
GJ Sills, MA Rogawski
Neuropharmacology 168, 107966, 2020
3132020
The system can't perform the operation now. Try again later.
Articles 1–20